Inaugural Emerging Scholars Symposium scheduled for April 30
One of the most innovative of the “high-risk, high-reward” grant programs at the A. Alfred Taubman Medical Research Institute is the Emerging Scholars Program, which often is referred to as the “jewel in the crown” of the institute’s initiatives.
Not only do these grants support the current work of the best and brightest of the early-career clinician-scientists on the U-M Medical School faculty, they achieve the crucial goal of keeping our health science research pipeline full.
Talented, passionate physician-researchers with the vision and energy to solve complex medical puzzles should not be deterred for lack of funds. Thanks to the contributions of the generous donors who have pledged three years of funding for each scientist, the institute now is jump-starting the careers of 11 Emerging Scholars who combine their patient practice with cutting-edge research into cancer, neurological disorders and other complex diseases.
And now, the first-ever Emerging Scholars Symposium will present a morning of science featuring presentations by six of our remarkable Emerging Scholars, who are seeking new discoveries and treatments in fields ranging from ovarian cancer to major depression.
The Emerging Scholars Symposium will run from 10 a.m. to noon in the Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building at U-M. For a map to the AAT-BSRB, click here.
The symposium is open to the entire University of Michigan community and to the general public. No registration is required.
To view a short video about the Emerging Scholars program, click here.
The presenting Emerging Scholars and their talks are:
Ron Buckanovich , M.D., Ph.D. “Developing Cancer Stem Cell Targeted Therapy to Prevent Disease Recurrence”
Sung Won Choi, M.D. “Histone deacetylase inhibition in graft-vs.-host disease”
Erika Newman , M.D. “Targeting Nonhomologous End-joining in Therapy-resistant Neuroblastoma”
Brian Mickey, M.D., Ph.D. “Biomarker Discovery for Refractory Mood Disorders”
Parag Patil, M.D., Ph.D. “Treating Movement Disorders and Depression with Deep-Brain Stimulation”
Srijan Sen, M.D., Ph.D. “Medical Internship as a Model to Identify Biological Predictors of Depression Under Stress”
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
2016 Art+Science Event Set for April 21
Save the date for another gala art auction to benefit the life-saving research of the Taubman Scholars.
Taubman Scholars: Reflections on Alfred Taubman
Eminent scientists say his curiosity, interest and vision changed the course of medical science.
news & events
In the News
Taubman Emerging Scholar makes strides against cancer
Erika Newman, M.D., has identified a characteristic of deadly childhood neuroblastoma that may pave the way for more effective treatments.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.